Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Can this be confirmed?

Dividends should prove a more certain way to see share volume and price growth. A few cents a couple times a year would bring significant returns at the current share price and it would seem could attract greater interest from investors of every stripe. Here's to hope...

Share
New Message
Please login to post a reply